A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer

Michelle Elvington, Yuxiang Huang, B. Paul Morgan, Fei Qiao, Nico Van Rooijen, Carl Atkinson, Stephen Tomlinson

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Fingerprint

Dive into the research topics of 'A targeted complement-dependent strategy to improve the outcome of mAb therapy, and characterization in a murine model of metastatic cancer'. Together they form a unique fingerprint.

Chemical Compounds

Medicine & Life Sciences